Clinical features and diagnostic tools in idiopathic inflammatory myopathies
- 12 November 2021
- journal article
- other
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 59 (4) , 219-240
Abstract
Idiopathic inflammatory myopathies (IIMs) are rare autoimmune disorders affecting primarily muscles, but other organs can be involved. This review describes the clinical features, diagnosis and treatment for IIMs, namely polymyositis (PM), dermatomyositis (DM), sporadic inclusion body myositis (sIBM), immune-mediated necrotizing myopathy (IMNM), and myositis associated with antisynthetase syndrome (ASS). The diagnostic approach has been updated recently based on the discovery of circulating autoantibodies, which has enhanced the management of patients. Currently, validated classification criteria for IIMs allow clinical studies with well-defined sets of patients but diagnostic criteria to guide the care of individual patients in routine clinical practice are still missing. This review analyzes the clinical manifestations and laboratory findings of IIMs, discusses the efficiency of modern and standard methods employed in their workup, and delineates optimal practice for clinical care. Α multidisciplinary diagnostic approach that combines clinical, neurologic and rheumatologic examination, evaluation of electrophysiologic and morphologic muscle characteristics, and assessment of autoantibody immunoassays has been determined to be the preferred approach for effective management of patients with suspected IIMs.Keywords
This publication has 184 references indexed in Scilit:
- Most Patients With Cancer‐Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP‐2 or Transcription Intermediary Factor 1γArthritis & Rheumatism, 2013
- Autoimmune myopathies: autoantibodies, phenotypes and pathogenesisNature Reviews Neurology, 2011
- Pathophysiology of inflammatory and autoimmune myopathiesLa Presse Médicale, 2011
- Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathyArthritis & Rheumatism, 2011
- Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotypeNeuromuscular Disorders, 2009
- Tubuloreticular Structures in Different Types of Myositis: Implications for PathogenesisUltrastructural Pathology, 2008
- Anti-Mi-2 antibodiesAutoimmunity, 2005
- History and classification of polymyositis and dermatomyositisClinics in Dermatology, 1988
- Microvascular Deposition of Complement Membrane Attack Complex in DermatomyositisNew England Journal of Medicine, 1986
- Spontaneous electrical muscle fiber activity in polymyositis and dermatomyositisMuscle & Nerve, 1979